Research
Other open public research grants, etc.
List of adoption status for 2024 (Reiwa 6)
School of Medicine
Subsidy for Clinical Research on Industrial Accidents and Diseases (Ministry of Health, Labour and Welfare)
No. | Business name etc. | Selection category | Project number etc. | Research Director | Research Project Name | Grant amount Direct expenses (yen) |
Grant amount Indirect expenses (yen) |
1 | Clinical Research Project for Work-Related Diseases | New | 240201-02 | Seiki Hasegawa | Clinical trial aimed at expanding application of photoimmunotherapy to mesothelioma | 86,932,000 | 26,079,000 |
As of September 2024
Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare
No. | Business name etc. | Selection category | Project number etc. | Research Director | Research Project Name | Grant amount Direct expenses (yen) |
Grant amount Indirect expenses (yen) |
1 | AIDS Countermeasures Policy Research Project | continuation | 22HB1005 | Satoshi Hikasa | Research to resolve issues regarding emergency care for HIV-infected hemophilia patients | 8,200,000 | 2,460,000 |
As of September 2024
Japan Agency for Medical Research and Development (AMED) research grant
No. | Business name etc. | Selection category | Project number etc. | Research Director | Research Project Name | Contract amount Direct expenses (yen) |
Contract amount Indirect expenses (yen) |
1 | Drug Discovery Support Promotion Project Drug Discovery Comprehensive Support Project | continuation | 24nk0101388h0007 | Hiroshi Nishiura | Search for new drugs for the treatment of Sjogren's syndrome that regulate autoimmunity | 4,545,455 | 454,545 |
2 | Research Integrity and Advancement Model Development Support Project | continuation | 24oa0310013h0003 | Tsuyoshi Morimoto | Practical application of integrated learning of clinical research skills and research integrity for use by clinical researchers | 9,000,000 | 2,700,000 |
3 | Translational Research Program | continuation | 24ym0126121h0002 | Kenichi Yamahara | Development of innovative angiogenesis therapy using injectable cell scaffold (ICS-001) | 80,000,000 | 24,000,000 |
4 | Medical Device Research Results Deployed Project Development Practice Type | New | 24hma322035h0001 | Keiichiro Mukai | Development of a new cognitive behavioral therapy app for obsessive-compulsive disorder | 20,000,000 | 6,000,000 |
5 | Practical Research Project for Intractable Diseases | New | 24ek0109695h0001 | Osamu Tsukamoto | Development of a novel therapeutic agent for idiopathic dilated cardiomyopathy that restores sarcomere structure and contractility | 20,000,000 | 6,000,000 |
As of September 2024
Comprehensive research on PFAS (Ministry of the Environment)
No. | Business name etc. | Selection category | Project number etc. | Research Director | Research Project Name | Allocation amount (yen) |
1 | Comprehensive research on PFAS | New | - | Etsushi Kuroda | Experimental verification to elucidate the immunosuppressive and immunostimulatory effects of PFAS in immune diseases | 30,000,000 |
As of September 2024
Supported by the Japan Private School Promotion and Mutual Aid Corporation
No. | Business name etc. | Selection category | Project number etc. | Research Director | Research Project Name | Allocation amount (yen) |
1 | Academic Research Promotion Fund | continuation | - | Satoshi Ishido | Measures for inflammatory diseases caused by MHC class Ⅱ dysregulation | 4,300,000 |
As of September 2024
School of Pharmacy, School of Nursing, School of Rehabilitation
none
As of September 2024